Higher serum IL-28B levels in SLE patients with active disease (SLEDIA ≥ 10) were obtained when compared to patients with less active disease (SLEDIA < 10) (P = 0.047, Fig. 3H). Here, IFNL3 is linked to systemic lupus erythematosus.